Skip to main content
Caplight Logo









Scinus Cell Expansion

Scinus Cell Expansion

Private
ZeistHealthcare & Life Scienceshttps://www.scinus.com/

Last Round

Strategic

Mar 10, 2026

Total Funding Raised

$3.49M

Momentum

Top 25%

of companies Caplight tracks

Company Overview

Scinus Cell Expansion is a biotechnology company that develops and distributes a bioreactor technology platform for stem cell cultivation, intended to make cell therapies accessible globally.

Sector

Healthcare & Life Sciences

Verticals

Biotech Equipment, Medical Devices, Biotechnology, Clinical Trials, Smart Manufacturing

Business Model

B2B

Customer Profile

Hardware Sales, Hardware + Subscription, Services & Consulting

AI Layer

Application

Keywords

cell therapy manufacturingautomated bioreactorcell expansionsingle-use bioreactorGMP manufacturingcell and gene therapyCGT manufacturingautomated cell culturebenchtop bioreactorbiomanufacturingclosed system bioreactorbioprocessingsingle-use consumableslow-shear cell cultureprocess development servicesMSC expansionT-cell expansion

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Scinus Cell Expansion Comparables

Compare Scinus Cell Expansion with similar companies based on industry and business-model similarity.

Scinus Cell Expansion comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Aglaris
88%
BioThrust
87%
Astraveus
85%

Scinus Cell Expansion Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
StrategicMar 10, 2026
StrategicJun 13, 2019

Key People

Founding team and executive leadership

Erik Vossenaar

CEO & Executive Director

Executive Team

Scinus Cell Expansion Investors

Notable investors and investment history

Scinus Cell Expansion investors
InvestorRounds
Myosotis InvestmentsStrategic

Market signals

Structured signals derived from secondary market and firmographic data.

  • Mar 10, 2026

    Raised $3.5M led by Myosotis Investments

  • Dec 25, 2025

    Grew 23% QoQ from 13 to 16 employees.

Scinus Cell Expansion Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Scinus Cell Expansion Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Scinus Cell Expansion's valuation, stock price, and market status.

Firmographic Details

HeadquartersZeist
Employee Range14
Year Founded2016
Last FundingMar 10, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?